Simulations Plus (SLP) Reports In-Line Q3 EPS

Go back to Simulations Plus (SLP) Reports In-Line Q3 EPS

Simulations Plus Reports Third Quarter Fiscal 2023 Financial Results

July 6, 2023 4:06 PM EDT

Total revenue of $16.2 million and diluted earnings per share (EPS) of $0.20

Maintains full-year revenue guidance of $59.3 - $62.0 million (+10-15%) and EPS guidance of $0.63 - $0.67

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical drug discovery and development, today reported financial results for its third quarter of fiscal 2023, ended May 31, 2023.

Third Quarter Financial Highlights (Fiscal 2023 vs. Fiscal 2022)

Total revenue increased 9% to $16.2 million Software revenue increased 10% to $10.6 million, representing 65% of... More